文献速递妇科

遗传筛查在妇科恶性肿瘤中的当前与未来作用

Current and future role of genetic screening in gynecologic malignancies.
PubMed 文献 · Am J Obstet Gynecol · 2017-04-12

本文综述了与妇科恶性肿瘤相关的遗传突变,包括遗传性乳腺癌和卵巢癌及林奇综合征等,并讨论了针对高风险患者的筛查与降低风险方案。作者强调在咨询这些患者时需引入癌症遗传学专家,并建议与专科高风险门诊协作以集中管理多种癌症风险。

要点

  • 遗传性乳腺癌和卵巢癌及林奇综合征占妇科医生遇到突变的大多数。
  • 新发现的致病性遗传突变不断被揭示,但证据有限,难以指导预期癌症风险和降低风险策略。
  • 咨询这些患者时须引入癌症遗传学专家,并与专科高风险门诊协作集中管理。

核心结论

  • 遗传性癌症领域呈指数增长,新发现的致病突变迫使从业者面对证据有限的不确定性。
  • 鉴于信息更新速度,咨询这些患者时必须引入癌症遗传学专家。
  • 与专科高风险门诊协作可让患者在经验丰富的医生指导下集中管理多种癌症风险。

研究设计与样本

  • 综述,旨在呈现与妇科恶性肿瘤相关的遗传突变的当前文献,并提出筛查和降低风险选项。

主要发现

  • 遗传性乳腺癌和卵巢癌及林奇综合征占妇科医生遇到突变的大多数。
  • 新识别的致病遗传突变不断被揭示,并伴有相关恶性肿瘤风险。
  • 对于较少见的突变,预期癌症风险和适当降低风险策略的证据有限。

临床怎么用

  • 咨询这些患者时必须引入癌症遗传学专家。
  • 与专科高风险门诊协作(如可用)可让患者在经验丰富的医生指导下集中管理多种癌症风险。

局限性

  • 对于较少见的突变,预期癌症风险和适当降低风险策略的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The world of hereditary cancers has seen exponential growth in recent years. While hereditary breast and ovarian cancer and Lynch syndrome account for the majority of mutations encountered by gynecologists, newly identified deleterious genetic mutations continue to be unearthed with their associated risks of malignancies. However, these advances in genetic cancer predispositions then force practitioners and their patients to confront the uncertainties of these less commonly identified mutations and the fact that there is limited evidence to guide them in expected cancer risk and appropriate risk-reduction strategies. Given the speed of information, it is imperative to involve cancer genetics experts when counseling these patients. In addition, coordination of screening and care in conjunction with specialty high-risk clinics, if available, allows for patients to have centralized management for multiple cancer risks under the guidance of physicians with experience counseling these patients. The objective of this review is to present the current literature regarding genetic mutations associated with gynecologic malignancies as well to propose screening and risk-reduction options for these high-risk patients.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ring KL, Garcia C, Thomas MH, et al. Current and future role of genetic screening in gynecologic malignancies. Am J Obstet Gynecol. 2017. PMID: 28411145. doi:10.1016/j.ajog.2017.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。